AI is reshaping psychopharmacology—from TRD prediction to digital phenotyping—while exposing data limits, workflow hurdles, and safety risks in suicide tools.
Roy Perlis, MD
Advertisement
Articles by Roy Perlis, MD
AI may assist psychopharmacology by aiding suicide risk, digital phenotyping, and TRD care—while exposing EHR data limits and the need for smarter integration.
Brain Trust: Artificial Intelligence in Psychopharmacology, Promise and Pitfalls With Roy Perlis, MD
How AI can aid everyday psychiatry—TRD prediction, suicide risk, and smartphone phenotyping—plus why data quality and workflow still block adoption.
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Psychiatric Times
1
Remlifanserin for the Treatment of Alzheimer Disease Psychosis Receives FDA Fast Track Designation
2
Classic Drug, New Target: Lithium as Disease-Modifying in Alzheimer Dementia
3
The Psychiatric Impact of Cannabis Policy: More Than a Legal Framework
4
Future DSM Plans Overlook Core Problem of Validity
5